Systems, devices, and methods for integration of an analyte data reader and medication delivery device
AssigneeAbbott Diabetes Care Inc.
InventorsJean-Pierre Cole, Cherie A. Bulala, Theodore J. Kunich, Xuandong Hua, Hila F. Ralston
Life of this patent
Estimating the term…
Abstract
Systems, devices and methods are provided for the integration of an analyte data reader and a medication delivery device. The integrated device can include a medication delivery portion, wireless communications circuitry configured to receive data indicative of an analyte level, and electronics. The integrated device can also include one or more near-field communication (NFC) antennas. Example embodiments of adverse condition protection features of the integrated device are also provided.
Claims14
A method for preventing the injection of medication when an adverse condition is present, the method comprising:
- detecting an attempt by a user to use a medication delivery device;
- receiving, by the medication delivery device, data indicative of an analyte level from a sensor control device configured to be worn by a user;
- determining, by the medication delivery device, whether the received data indicative of the analyte level includes recent analyte level data;
- determining whether the adverse condition is present based on the received data indicative of the analyte level;
- and
- in response to either a determination that the received data indicative of the analyte level does not include the recent analyte level data, or a determination that the adverse condition is present, activating a lock-out mechanism for a predetermined duration of time and outputting a warning, wherein the lock-out mechanism is configured to prevent use of the medication delivery device, wherein the medication delivery device is an insulin pen, and wherein the lock-out mechanism comprises a latch mechanism configured to prevent activation of the medication delivery device for the predetermined duration of time.
A method for preventing injection of medication when an adverse condition is present, the method comprising:
- receiving, by the medication delivery device, data indicative of an analyte level from a sensor control device configured to be worn by a user;
- determining, by the medication delivery device, whether the received data indicative of the analyte level includes recent analyte level data;
- receiving, by the medication delivery device, an alert indicative of an adverse condition associated with the user;
- determining whether the adverse condition is present based on the received data indicative of the analyte level;
- and
- in response to either a determination that the received data indicative of the analyte level does not include the recent analyte level data, or a determination that the adverse condition is present, activating a lock-out mechanism for a predetermined duration of time and outputting a warning to the user, wherein the lock-out mechanism is configured to prevent use of the medication delivery device, wherein the medication delivery device is an insulin pen, and wherein the lock-out mechanism comprises a latch mechanism configured to prevent activation of the medication delivery device for the predetermined duration of time.
Dependencies are inferred from the claim text.